GALMED PHARMACEUTICALS LTD (GLMD)

IL0011313900 - Common Stock

0.3871  +0.04 (+9.97%)

After market: 0.3853 0 (-0.46%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
7.49M17.65M32.88M30.21M22.38M
Research and Development
3.57M13.00M27.22M26.08M18.18M
Selling, General, and Administrative Expenses
3.92M4.66M5.66M4.13M4.20M
Operating Income
-7.49M-17.65M-32.88M-30.21M-22.38M
Interest Income/Expense
591.00K-190.00K460.00K1.47M1.95M
Other Income/Expense
-11.00K-20.00K-40.00K-30.00K-30.00K
Income Before Taxes
-6.91M-17.87M-32.47M-28.77M-20.46M
Income Tax
N/AN/AN/A0.000.00
Net Income
-6.91M-17.87M-32.47M-28.77M-20.46M
EBITDA
-7.46M-17.61M-32.84M-30.17M-22.34M
 
Per Share Data
EPS Diluted Total Ops
-2.50-10.63-19.80-20.28-14.51
Non GAAP EPS
-3.26-10.50-5.52-1.35-0.97
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts